Evaluation of pharmacy students' blood pressure and heart rate measurement skills after completion of a patient assessment course

American Journal of Pharmaceutical Education

Volumn 71, Issue 1, 2007, Pages

  McCall, Kenneth L ^a,b   Raehl, Cynthia ^a   Nelson, Sherida ^a   Haase, Krystal ^a   Fike, David S ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b Texas Tech School of Pharmacy   (United States)

Author keywords

Blood pressure; Heart rate; Pharmacy students; Physical assessment; Vital signs

Indexed keywords

ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL EDUCATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; EDUCATION PROGRAM; HEART RATE; HUMAN; PATIENT ASSESSMENT; PHARMACEUTICAL CARE; PHARMACY STUDENT; SKILL; BLOOD PRESSURE; CLINICAL COMPETENCE; EDUCATION; METHODOLOGY; STANDARD; VALIDATION STUDY;

BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CLINICAL COMPETENCE; EDUCATION, PHARMACY; HEART RATE; HUMANS; STUDENTS, PHARMACY;

EID: 33947276357     PISSN: 00029459     EISSN: 15536467     Source Type: Journal    
DOI: 10.5688/aj710101     Document Type: Article

References (24)

1. Standards and guidelines for the professional program in pharmacy leading to the doctor of pharmacy degree. Available at: http://www.acpeaccredit.org/ pdf/ACPE_Revised_PharmD_Standards_Adopted_Jan152006.pdf Accessed March 16, 2006.
2. da Camara CC, D'Elia RP, Swanson LN. Survey of physical assessment course offerings in American colleges of pharmacy. Am J Pharm Educ. 1996;60:343-7.
3. Chereson RS, Bilger R, Mohr S, Wuller C. Design of a phrarmaceutical care laboratory: a survey of practitioners. Am J Pharm Educ. 2005;69(1):Article 3.
4. White WB, Berson AS, Robbins C, Jamieson MJ, Prisant LM, Roccella E, Sheps SG. National standard for measurement of resting and ambulatory blood pressures with automated sphygmomanometers. Hypertension. 1993;21:504-9.
5. Anwar YA, Giacco S, McCabe EJ, Tendler BE, White WB. Evaluation of the efficacy of the Omron HEM-737 IntelliSense device for use on adults according to the recommendations of the Association for the Advancement of Medical Instrumentation. Blood Press Monit. 1998;3:261-5.
6. O'Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. Br Med J. 2001;322:531-6.
7. Omron 711-AC Instruction Manual. Omron Healthcare, Inc. Bannockburn, Illinois. 2005.
8. Perloff D, Grim C, Flack J, et al, for the Writing Group. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88:2460-2467.
9. O'Brien E, Petrie J, Littler WA, de Swiet M, Padfield PL, Altman D, et al. The British Hypertension Society protocol for the evaluation of blood pressure measuring devices. J Hypertens 1993;11(suppl 2):S43-63.
10. Veiga EV, Nogueira MS, et al. Assessment of the techniques of blood pressure assessment by health professionals. Arquivos Brasileiros de Cardiologia. 2003;80:89-93.
11. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199-206.
12. Pickering TG et al. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: Blood pressure measurement in humans. Hypertension. 2005;45:142-61.
13. Supernaw RB, Mehvar R. Methodology for the assessment of competence and the definition of deficiencies of students in all levels of the curriculum. Am J Pharm Educ. 2002;66:1-4.
14. Mehvar R, Supernaw RB. Outcome assessment in a PharmD program: The Texas Tech Experience. Am J Pharm Educ. 2002;66:219-23.
15. Chobanian AV, et al and the National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560-72.
16. Bond CA, Monson R. Sustained improvement in drug documentation, compliance, and disease control: a four-year analysis of an ambulatory care model. Arch Intern Med. 1981;141:1441-4.
17. McGhan WF, Stimmel GL, et al. A comparison of pharmacists and physicians on the quality of prescribing for ambulatory hypertensive patients. Med Care. 1983;21:435-44.
18. Morse GD, Douglas JB, et al. Effect of pharmacist intervention on control of resistant hypertension. Am J Hosp Pharm. 1986;43:905-9.
19. Park JJ, Kelly P, et al. Comprehensive pharmaceutical care in the chain setting: drug therapy monitoring and counseling by pharmacists contributed to improved blood pressure control in study patients. J Am Pharm Assoc. 1996;36:443-51.
20. Erickson SR, Slaughter R, Halapy H. Pharmacists' ability to influence outcomes of hypertension therapy. Pharmacotherapy. 1997;17:140-7.
21. Carter BL, Barnette DJ, et al. Evaluation of hypertensive patients after care provided by community pharmacists in a rural setting. Pharmacotherapy. 1997;17:1274-85.
22. Solomon DK, Portner TS, et al. Part 2. Clinical and economic outcomes in the hypertension and COPD arms of a multicenter outcomes study. J Am Pharm Assoc. 1998;38:574-85.
23. Bodgen PE, Abbott RD, et al. Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension. J Gen Intern Med. 1998;13:740-5.
24. Mehos BM, Saseen JJ, MacLaughlin EJ. Effect of pharmacist intervention and initiation of home blood pressure monitoring in patients with uncontrolled hypertension. Pharmacotherapy. 2000;20:1384-9.